• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chemotherapy of metastatic bladder cancer.

作者信息

Yagoda A

出版信息

Cancer. 1980 Apr 15;45(7 Suppl):1879-88.

PMID:7189443
Abstract
摘要

相似文献

1
Chemotherapy of metastatic bladder cancer.
Cancer. 1980 Apr 15;45(7 Suppl):1879-88.
2
Induction chemotherapy with cisplatin and cyclophosphamide and maintenance chemotherapy with doxorubicin and 5-FU in advanced urinary bladder tumors.
Cancer Treat Rep. 1983 Feb;67(2):200-1.
3
Chemotherapy for advanced urothelial cancer.晚期尿路上皮癌的化疗
Semin Urol. 1983 Feb;1(1):60-74.
4
M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium.
Prog Clin Biol Res. 1988;260:481-5.
5
Methotrexate and mitomycin for patients with metastatic transitional cell carcinoma of the urinary tract.
Cancer Treat Rep. 1983 May;67(5):503-4.
6
[Combination chemotherapy with M-VAC protocol in metastatic urothelial cancer].[采用M-VAC方案的联合化疗治疗转移性尿路上皮癌]
Harefuah. 1999 Feb 15;136(4):268-71, 340, 339.
7
Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.浸润性尿路上皮癌的辅助化疗：甲氨蝶呤、长春新碱、顺铂、环磷酰胺、阿霉素和博来霉素（MVP-CAB）方案的经验：初步报告
Jpn J Clin Oncol. 1993 Oct;23(5):291-8.
8
Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.甲氨蝶呤、长春碱、阿霉素和顺铂化疗对下尿路移行细胞癌淋巴结转移患者的影响。
Semin Urol. 1993 Feb;11(1):14-9.
9
[M-VAC chemotherapy for advanced urothelial cancer--side effects and their management].[M-VAC化疗用于晚期尿路上皮癌——副作用及其处理]
Hinyokika Kiyo. 1994 Aug;40(8):677-82.
10
Chemotherapy for metastatic bladder cancer; the EORTC experience.
Prog Clin Biol Res. 1988;260:471-9.

引用本文的文献

1
Coming of Age of Immunotherapy of Urothelial Cancer.免疫治疗膀胱癌的时代到来了。
Target Oncol. 2021 May;16(3):283-294. doi: 10.1007/s11523-021-00804-7. Epub 2021 Mar 12.
2
Bladder cancer.膀胱癌
Br Med J (Clin Res Ed). 1981 Mar 28;282(6269):1012-3.
3
Phase II study of VP 16-213 (etoposide) in metastatic transitional cell urothelial cancer.
Cancer Chemother Pharmacol. 1984;12(1):64-5. doi: 10.1007/BF00255913.
4
Phase-II trials in patients with urothelial tract tumors. Memorial Sloan-Kettering Cancer Center.
Cancer Chemother Pharmacol. 1983;11 Suppl:S9-12. doi: 10.1007/BF00256709.
5
Combination chemotherapy including adriamycin for advanced transitional cell carcinoma of the urinary tract.
Cancer Chemother Pharmacol. 1983;11 Suppl:S38-42. doi: 10.1007/BF00256716.
6
Pharmacokinetics of high-dose methotrexate in dogs. An experimental model with diffusion chambers.
Cancer Chemother Pharmacol. 1983;11(3):172-6. doi: 10.1007/BF00254199.
7
Chemotherapy of advanced transitional cell carcinoma of the uroepithelium.
Cancer Chemother Pharmacol. 1983;11 Suppl:S1-4. doi: 10.1007/BF00256707.
8
Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line.使用人膀胱癌细胞系比较化疗药物的细胞毒性活性。
Urol Res. 1985;13(1):27-34. doi: 10.1007/BF00571753.
9
Results of systemic chemotherapy of advanced bladder carcinomas (phase II study).
Int Urol Nephrol. 1987;19(1):75-9. doi: 10.1007/BF02549681.
10
Effects of single chemotherapeutic agents on development of urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in rats.单一化疗药物对N-丁基-N-(4-羟基丁基)亚硝胺（BBN）诱导的大鼠膀胱肿瘤发生发展的影响。
Urol Res. 1987;15(6):329-34. doi: 10.1007/BF00265661.